Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors

Affiliations

• ¹ Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK.
• ² Clinical Trials Research Unit, University of Leeds, Leeds, UK.
• ³ The Christie NHS Foundation Trust, Manchester, UK.
• ⁴ St James Institute of Oncology, Leeds, UK.
• ⁵ Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.
• ⁶ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy.
• ⁷ Laboratory for Transcriptome Technology, RIKEN Centre for Integrative Medical Sciences, Yokohama, Japan.
• ⁸ Department of Haematology, University Hospital Limerick, Limerick, Ireland.
• ⁹ Department of Oncology, University of Oxford, Oxford, UK.
• ¹⁰ Haematological Malignancy Diagnostic Service, St James Hospital, Leeds, UK.
• ¹¹ Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.